stress

Search documents
Ovintiv May Generate Over $6 Per Share In 2025 Free Cash Flow (Rating Upgrade)
Seeking Alpha· 2025-05-24 10:31
Group 1 - Ovintiv (OVV) is projected to generate over $1.6 billion in free cash flow in 2025 at current strip prices [1] - The anticipated free cash flow will enable Ovintiv to reduce its net debt to $5 billion by the end of the forecast period [1] - The analysis is provided by Aaron Chow, a top-rated analyst with over 15 years of experience, focusing on value opportunities and distressed plays in the energy sector [1]
Viper Energy: Recent Transactions Increase Its Oil Production By Over 60%
Seeking Alpha· 2025-05-23 03:15
Group 1 - The article promotes a free two-week trial for the investment group Distressed Value Investing, which offers exclusive research on various companies and investment opportunities [1] - The investment group focuses on value opportunities and distressed plays, particularly in the energy sector [2] - The author, Aaron Chow, has over 15 years of analytical experience and previously co-founded a mobile gaming company that was acquired by PENN Entertainment [2] Group 2 - The article emphasizes that past performance is not indicative of future results and does not provide specific investment recommendations [3] - It clarifies that the analysts contributing to the platform may not be licensed or certified by any regulatory body [3]
Vital Energy: Hedges Protect Its 2025 Free Cash Flow
Seeking Alpha· 2025-05-22 21:00
We are currently offering a free two-week trial to Distressed Value Investing . Join our community to receive exclusive research about various companies and other opportunities along with full access to my portfolio of historic research that now includes over 1,000 reports on over 100 companies.Vital Energy, Inc. (NYSE: VTLE ) is now projected to generate around $267 million in 2025 free cash flow at current strip. This is only modestly lower than what I had projected for Vital before oilAaron Chow, aka Ele ...
Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction
Globenewswire· 2025-05-21 11:00
Investigator-initiated Phase 2 trial to evaluate TNX-102 SL's potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) Trial is sponsored by the University of North Carolina (UNC) and supported by a grant from the U.S. Department of Defense Topline results from the trial are expected in the second half of 2026 CHATHAM, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company with market ...
Dorchester Minerals: Reviewing Its Potential Results At Low-$60s Oil
Seeking Alpha· 2025-05-20 05:30
We are currently offering a free two-week trial to Distressed Value Investing . Join our community to receive exclusive research about various companies and other opportunities along with full access to my portfolio of historic research that now includes over 1,000 reports on over 100 companies.Dorchester Minerals (NASDAQ: DMLP ) declared a Q1 2025 distribution of roughly $0.726 per unit. This was approximately 2% less than its Q4 2024 distribution. Going forward, I expect flat to slightly declining organic ...
Magnolia Oil & Gas: Strong Performance From Its Giddings Wells
Seeking Alpha· 2025-05-16 20:35
We are currently offering a free two-week trial to Distressed Value Investing . Join our community to receive exclusive research about various companies and other opportunities along with full access to my portfolio of historic research that now includes over 1,000 reports on over 100 companies.Magnolia Oil & Gas (NYSE: MGY ) delivered strong Q1 2025 production results with total production around 3% above its guidance. As a result of its well outperformance and improved capital efficiency, Magnolia has als ...
Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories
Globenewswire· 2025-05-14 12:40
Clear Regulatory Path to Clinical Trials for Intranasal PTSD Therapy Targeting Multi-Billion-Dollar MarketSARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has entered into an agreement with Frontage Laboratories, a global full-service CRO (contract research organization), for a Food and Drug Administration (FDA) requested 7 ...
Caliber Hospitality Development Launches to Pursue Opportunistic and Distressed Hotel Investments
GlobeNewswire News Room· 2025-05-13 11:30
SCOTTSDALE, Ariz., May 13, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced the launch of Caliber Hospitality Development, LLC (“CHD”), a joint venture between Caliber and GIA Hospitality, LLC (“GIA”). CHD will serve as the exclusive development platform for Caliber’s opportunistic hospitality investments, with a focus on acquiring distressed hotel assets and developing extended stay hotels in high-demand markets. The joint venture was seeded wi ...
AMC Entertainment: Heavy Cash Burn In Q1 2025, But Q2 Looks Much Better
Seeking Alpha· 2025-05-10 12:42
Group 1 - The article promotes a free two-week trial for the investment group Distressed Value Investing, which offers exclusive research on various companies and investment opportunities [1] - The author, Aaron Chow, has over 15 years of analytical experience and co-founded a mobile gaming company that was acquired by PENN Entertainment, indicating a strong background in the gaming and entertainment sectors [2] - Distressed Value Investing focuses on value opportunities and distressed plays, particularly in the energy sector, highlighting a specific investment strategy [2] Group 2 - The article emphasizes that past performance is not indicative of future results, which is a common disclaimer in investment discussions [3] - It clarifies that no recommendations or advice are being provided regarding the suitability of investments for particular investors [3] - The analysts contributing to the article may not be licensed or certified, suggesting a diverse range of perspectives but also varying levels of expertise [3]
Permian Resources: Increasing Scale With Its Northern Delaware Basin Acquisition
Seeking Alpha· 2025-05-09 19:00
We are currently offering a free two-week trial to Distressed Value Investing . Join our community to receive exclusive research about various companies and other opportunities, along with full access to my portfolio of historic research that now includes over 1,000 reports on over 100 companies.Permian Resources Corporation (NYSE: PR ) made a $608 million acquisition that should boost its production by several percent going forward. At $70 WTI oil and $2.00 Waha natural gas, I believe that Permian can now ...